Cart
sales@molnova.com
P 218
CAS No. 1142407-60-0
P 218( —— )
Catalog No. M36513 CAS No. 1142407-60-0
P 218 is a novel DHFR inhibitor with antimalarial activity and antifolate effects and can be used to study Buruli ulcer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 300 | In Stock |
|
| 10MG | 445 | In Stock |
|
| 25MG | 731 | In Stock |
|
| 50MG | 1004 | In Stock |
|
| 100MG | 1349 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2688 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameP 218
-
NoteResearch use only, not for human use.
-
Brief DescriptionP 218 is a novel DHFR inhibitor with antimalarial activity and antifolate effects and can be used to study Buruli ulcer.
-
DescriptionP 218 is a novel DHFR inhibitor with antimalarial activity and antifolate effects and can be used to study Buruli ulcer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDHFR
-
RecptorDHFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1142407-60-0
-
Formula Weight396.87
-
Molecular FormulaC18H25ClN4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.O=C(O)CCC=1C=CC=CC1OCCCOC=2C(=NC(=NC2CC)N)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DS44960156
DS44960156 is a novel selective inhibitor of methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) that inhibits both MTHFD2 and MTHFD1 and can be used in cancer research.
-
Piritrexim
Piritrexim (BW 301U) is an orally available fat-soluble dihydrofolate reductase inhibitor with pulmonary toxicity used in the study of uroepithelial carcinoma and metastatic breast cancer.
-
Brodimoprim
Brodimoprim is an inhibitor of dihydrofolate reductase(DHFR). Brodimoprim is also a long-acting broad-spectrum antibacterial agent characterized by a good pharmacokinetic profile.
